XML 42 R32.htm IDEA: XBRL DOCUMENT

STOCKHOLDERS' DEFICIT (Tables)

9 Months Ended

Sep. 30, 2023

Schedule of Share-based Compensation Arrangements by Share-based Payment Award

Stock-based compensation expense for the three and nine months ended September 30, 2023 and 2022, is included in the Company’s Consolidated Statements of Operations as follows (in thousands):


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
Cost of revenue	$	1,503	$	4,366	$	3,607	$	23,287
Research and development	334		5,210		1,144		20,269
Sales and marketing	517		(720)		1,561		8,870
General and administrative1,2	12,507		20,897		35,102		114,122
Total stock-based compensation expense1,2	$	14,861	$	29,753	$	41,414	$	166,548

1 Includes $(0.1) million and $0.6 million that was recorded as an adjustment to accrued expenses and other within total current liabilities during the three and nine months ended September 30, 2022, respectively.

2 Includes $1.0 million of stock-based compensation that were provided in severance as part of restructuring charges incurred during the three and nine months ended September 30, 2022.